U.S. flag

An official website of the United States government

NM_000112.4(SLC26A2):c.1535C>A (p.Thr512Lys) AND Osteochondrodysplasia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 25, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004700186.1

Allele description [Variation Report for NM_000112.4(SLC26A2):c.1535C>A (p.Thr512Lys)]

NM_000112.4(SLC26A2):c.1535C>A (p.Thr512Lys)

Gene:
SLC26A2:solute carrier family 26 member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q32
Genomic location:
Preferred name:
NM_000112.4(SLC26A2):c.1535C>A (p.Thr512Lys)
HGVS:
  • NC_000005.10:g.149981128C>A
  • NG_007147.2:g.22246C>A
  • NM_000112.4:c.1535C>AMANE SELECT
  • NP_000103.2:p.Thr512Lys
  • LRG_684:g.22246C>A
  • NC_000005.9:g.149360691C>A
Protein change:
T512K; THR512LYS
Links:
OMIM: 606718.0013; dbSNP: rs121908078
NCBI 1000 Genomes Browser:
rs121908078
Molecular consequence:
  • NM_000112.4:c.1535C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Osteochondrodysplasia
Identifiers:
MONDO: MONDO:0005516; MedGen: C0029422

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005205473Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Jun 25, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia.

Bonafé L, Hästbacka J, de la Chapelle A, Campos-Xavier AB, Chiesa C, Forlino A, Superti-Furga A, Rossi A.

J Med Genet. 2008 Dec;45(12):827-31. doi: 10.1136/jmg.2007.057158. Epub 2008 Aug 15.

PubMed [citation]
PMID:
18708426
PMCID:
PMC4361899

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005205473.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: SLC26A2 c.1535C>A (p.Thr512Lys) results in a non-conservative amino acid change located in the SLC26A/SulP transporter domain (IPR011547) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 251120 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SLC26A2 causing Sulfate Transporter-Related Osteochondrodysplasia (4.8e-05 vs 0.003), allowing no conclusion about variant significance. c.1535C>A has been reported in the literature in multiple individuals affected with diastrophic dysplasia (DTD) (example: Bonafe_2008). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect resulted in sulfate transporter activity similar to non-transfected cells or transfected with the vector alone (example: Bonafe_2008). The following publication has been ascertained in the context of this evaluation (PMID: 18708426). ClinVar contains an entry for this variant (Variation ID: 4099). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024